http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285981-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6b2aa9312d14cd3baf8ea70eff572bf |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 |
| filingDate | 2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a6b26fc7da44bbff3a46a8adeb5f1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffb0bb561306be960bf93d87402a05a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ef53b495fb7d714086aa30b76c1ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d41587a8bb2946427a9430d0d22e2f22 |
| publicationDate | 2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-10285981-B2 |
| titleOfInvention | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| abstract | A method for treating amyotrophic lateral sclerosis (ALS) in a subject in need thereof comprising administering to said subject an effective amount of (6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole or pharmaceutically acceptable salt thereof, wherein said subject is a treatment responder. In certain embodiments, said subject is a subject with definite amyotrophic lateral sclerosis, a subject with amyotrophic lateral sclerosis symptom onset duration of less than about 18 months, a subject with a high level of serum creatinine, a subject with concomitant riluzole administration and combinations thereof. |
| priorityDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 596.